NCT01461616View on ClinicalTrials.gov

Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP Axis

PHASE3CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

NPH

equal doses of NPH insulin, insulin Detemir and insulin glargine injection

DRUG

Detemir

equal doses of NPH insulin, insulin Detemir and insulin glargine injection

DRUG

Glargine

equal doses of NPH insulin, insulin Detemir and insulin glargine injection

Trial Locations (1)

8000

Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus

All Listed Sponsors
lead

University of Aarhus

OTHER

NCT01461616 - Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP Axis | Biotech Hunter | Biotech Hunter